NCT01256411 A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension Status COMPLETED Phase PHASE2
NCT01255462 Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration Status COMPLETED Phase PHASE1
NCT01254227 Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload Status COMPLETED Phase PHASE2
NCT01254188 Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients Status COMPLETED Phase PHASE3
NCT01253629 Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome Status COMPLETED Phase PHASE2
NCT01253161 Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) Status COMPLETED Phase PHASE2
NCT01252251 RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma Status COMPLETED Phase PHASE2
NCT01250951 This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload. Status COMPLETED Phase PHASE4
NCT01250171 The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients Status COMPLETED Phase PHASE2
NCT01249456 Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients Status COMPLETED Phase N/A
NCT01243944 Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial) Status COMPLETED Phase PHASE3
NCT01242813 Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS). Status COMPLETED Phase PHASE2
NCT01242774 Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE1
NCT01240655 A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01240642 An Open-label, Dose Escalation Multi-center Study in Patients With Advanced Cancer to Determine the Infusion Rate Effect of ASA 404 With Paclitaxel Plus Carboplatin Regimen or Docetaxel on the Pharmacokietics of Free and Total ASA404 Status TERMINATED Phase PHASE1
NCT01237873 Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension Status COMPLETED Phase PHASE3
NCT01237236 A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma. Status COMPLETED Phase PHASE1
NCT01235962 A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) Status COMPLETED Phase PHASE3
NCT01232894 12-week Open-label Evaluation of Efficacy and Safety of Indacaterol Status COMPLETED Phase PHASE3